Pulmonary aspiration during upper endoscopy in a patient prescribed semaglutide

Oct 18, 2024Revista espanola de enfermedades digestivas

Lung choking risk during upper digestive tract exam in a patient taking semaglutide

AI simplified

GLP-1 TherapiesGLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗

Abstract

A case of pulmonary aspiration occurred during upper endoscopy in a patient prescribed semaglutide, a type of glucagon-like peptide-1 receptor agonist (GLP-1RA).

  • GLP-1 receptor agonists are increasingly used for managing type 2 diabetes and obesity.
  • There are concerns regarding gastric emptying delays caused by GLP-1RAs, which may lead to gastric food retention.
  • Observational studies suggest an increased incidence of gastric food retention in patients using long-acting GLP-1RAs like semaglutide.
  • The relationship between GLP-1RAs and pneumonia aspiration during endoscopy is not well established.
  • This report presents a specific instance of pulmonary aspiration linked to semaglutide use.

AI simplified

Related papers

Sep '24
Risk of Lung Inflammation from Stomach Fluid Inhalation After Planned Upper Digestive Tract Exam in Patients Taking Glucagon-Like Peptide-1 Medicines
cited by 7 papers
journal article
Aug '24
How GLP-1 receptor drugs affect digestion: causes, treatment, and future possibilities
top 1% journal
cited by 93 papers
research support, non-u.s. gov't
Mar '24
Real-World Effects of Weekly GLP-1 Medicines Compared to DPP-4 Inhibitors on Blood Sugar and Weight in Type 2 Diabetes
top 30% journal
cited by 7 papers
observational study
Mar '24
Medications That Activate Glucagon-Like Peptide-1 Receptors May Increase Solid Stomach Residue During Upper Endoscopy, Especially in People with Complicated Diabetes
top 5% journal
cited by 45 papers
journal article
Jul '21
Clinical views on using under-the-skin versus oral forms of semaglutide
top 10% journal
cited by 53 papers
research support, non-u.s. gov't

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #28
Semaglutide linked to 74-fold higher risk of vision-threatening eye condition
1 week ago3 studies
issue #27
GLP-1 drugs linked to 18% lower risk of substance use disorders in 524,817 veterans
2 weeks ago7 studies
issue #26
86.5% of patients on semaglutide or tirzepatide lost at least 5% of body weight at 6 months in Medicaid study
3 weeks ago7 studies
issue #25
GLP-1 drugs linked to 20% lower dementia risk in diabetic kidney patients
4 weeks ago7 studies
issue #24
Tirzepatide beats semaglutide for weight loss by 6.1% in head-to-head comparison
5 weeks ago7 studies
issue #23
Bariatric Surgery vs. GLP-1s for cardiovascular risk
6 weeks ago7 studies
issue #22
GLP-1 drugs linked to better pregnancy rates in PCOS women and reduced cancer risk in diabetes patients
7 weeks ago7 studies
issue #21
GLP-1 drugs may fight addiction, and reduce alcohol consumption
8 weeks ago7 studies
issue #20
GLP-1 drugs show promise for kidney transplant patients and Alzheimer's, but may increase eye problems
9 weeks ago7 studies
issue #19
GLP-1 drugs cut heart attack risk by 22% vs competitors, but may increase vision loss risk
10 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief